Solifenacin tartrate
酒石酸索利那新
Report date: 2024/08/14 20:00:41
NME
Base Information
Drug NameSolifenacin tartrate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAarhus UniversityUniversity of Arkansas
Inactive CompaniesHanmi Pharmaceutical Co LtdMansoura University
Active Indications
Inactive Indications